FDA Approved: TAZAROTENE — Supplemental Application (Mayne Pharma)

View source ↗

Summary

The FDA approved a supplemental application for tazarotene submitted by Mayne Pharma, extending its approved use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Plaque Psoriasis

Drugs mentioned

• TAZAROTENE (TAZAROTENE)

Snippet

SUPPL AP for TAZAROTENE (TAZAROTENE)